Skip to main content

Strengthen your value story with HEOR

Tap into our expertise in health economics and outcomes research (HEOR).

HEOR is a field of research that provides real-world data and insights to demonstrate the clinical and economic value of pharmaceutical products and medical devices. 

Unlike clinical trials, which demonstrate safety and efficacy, our research helps demonstrate therapeutic value and impact.

Recent news and publications from Optum HEOR experts

Meet with us at upcoming events

Schedule now

Answer your toughest research questions

Consider the following questions as you address health outcomes in the life sciences space.


Disease burden

How are patients impacted?

Unmet need

What gaps in care can your product help address?

Treatment patterns

How are your medications used to treat patients?

Total cost of care

Are there medical cost offsets associated with a treatment option?


Do patients take their medication correctly?

Comparative effectiveness

How do the outcomes of patients using the competitor’s product compare?


Providing actionable HEOR data to prove cost-effectiveness

See how we worked with a medical device company to prove their device was more cost-effective than the current standard of care.

Paul Dluzniewski

Leaders with deep domain expertise and industry knowledge

Our capabilities and experience span many therapeutic areas, including oncology, infectious disease and cardiovascular disease. Get to know our leaders.

Voice-to-Claim™ research: Explore patient and provider journeys

Investigate patient and physician attitudes about treatment and insights into how decisions are made.


Explore therapeutic areas

Our therapeutic focus supports the development of disease-specific capabilities and infrastructure.

Cardiovascular disease

Developing research to advance the treatment of CVD, including dysrhythmia, hypertension and heart failure

Central nervous system and behavioral health

Offering insights in Alzheimer’s, dementia, depression, and more

Diabetes and other endocrine diseases

Gaining insight on diabetes and other endocrine conditions

Infectious disease

Combining real-world data and extensive therapeutic expertise to showcase the value of ID therapies

Oncology and immunology

Offering expertise in solid tumors, hematologic malignancies and other inflammatory conditions

Respiratory disease

Supporting our clients in evidence generation for asthma, COPD and other respiratory disease products

Rare disease

Reimagining services for rare disease and developing advanced therapies

Sell sheet

Explore our HEOR capabilities

Design and conduct studies to generate real-world evidence of the value of medications and medical devices.


Let us help you connect the dots

From data to insight to action, we catalyze innovation and commercial impact. Work with us on your HEOR needs.


Find our HEOR experts at upcoming events

Sept 30 - Oct 1, 2024
Phoenix, AZ

Meet with us to discuss your HEOR needs.

Request a meeting

Oct 14 - 17, 2024
Las Vegas, NV

Meet with us to discuss your HEOR needs.

Request a meeting

Nov 17 - 20, 2024
Barcelona, Spain

Meet with us to discuss your HEOR needs.

Request a meeting

Dec 7 - 10, 2024
San Diego, CA

Meet with us to discuss your HEOR needs.

Request a meeting

Related content

Solve contract challenges for gene therapies

There are hurdles to overcome for value-based contracts to become widespread.

11 things life sciences leaders need to know

We identified 11 trends worth watching.

Novel data collection for a difficult-to-study condition

To build a more complete picture of the patient burden, the Optum HEOR team investigates patients’ experiences with their treatment journey.

Sleep treatment across the ages

Combining real-world data and primary research helps us better understand insomnia.

Complementary solutions

Engage payers with value-based contracts

Assess the fit, develop metrics and track care outcomes over time.

Gain greater insights through clinicogenomics

Better understand diseases and drug development opportunities.

Generate evidence with real-world data

Derive evidence from the unmatched depth and scale of our data assets.